Equity Overview
Price & Market Data
Price: $43.53
Daily Change: $0.00 / 0.00%
Daily Range: $43.53 - $46.92
Market Cap: $3,165,119,406
Daily Volume: 841
Performance Metrics
1 Week: -0.54%
1 Month: 14.91%
3 Months: -32.83%
6 Months: -42.56%
1 Year: -30.07%
YTD: -38.39%
Company Details
Employees: 481
Sector: Health technology
Industry: Biotechnology
Country: Denmark
Details
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.